US stock futures rise amid tech strength, Fed succession watch

U.S. stock futures advanced, propelled by tech strength, notably Apple's $600 billion U.S. investment pledge, which buoyed the NASDAQ while the S&P 500 and Dow declined. Significant individual stock movements included Eli Lilly's 14% slump on disappointing weight-loss drug trial results, Airbnb's 8% drop on a weaker H2 outlook, and Intel's decline following Trump's call for its CEO's resignation. Concurrently, cooling labor market data solidified expectations for a September Fed rate cut, now nearing 90% probability, amidst ongoing speculation regarding the next Fed Chair and the implementation of Trump's reciprocal tariffs, which included a semiconductor duty largely mitigated by U.S. manufacturing exemptions.

Analysis

The market is exhibiting significant divergence, with U.S. stock futures rising on technology sector strength while the broader market shows signs of weakness. Nasdaq 100 futures advanced 0.2%, primarily buoyed by Apple Inc. (AAPL) following its pledge to invest $600 billion in the U.S. This positive catalyst for tech contrasted sharply with the performance of the S&P 500 and Dow, which fell 0.1% and 0.5% respectively during the regular session. The weakness was driven by severe, company-specific headwinds, most notably a 14% slump in Eli Lilly (LLY) shares after its weight-loss drug trial results proved less effective than a competing product from Novo Nordisk. Further pressure came from an 8% decline in Airbnb (ABNB) on a weaker second-half growth outlook and a 3% drop in Intel (INTC) after the president called for its CEO's resignation. On the macroeconomic front, rising weekly jobless claims are reinforcing expectations for a Federal Reserve interest rate cut in September, with markets now pricing in a nearly 90% probability of a 25 basis point reduction. This is occurring amidst ongoing political developments, including speculation over Fed Chair Jerome Powell's successor and the implementation of new semiconductor tariffs, whose market impact appears muted by exemptions for firms with U.S. manufacturing operations.

Key Decisions for Investors

• Given the clear divergence between strong-performing tech mega-caps like Apple and underperforming sectors, investors should assess portfolio concentration and consider rebalancing away from companies facing distinct fundamental or political headwinds, such as Eli Lilly and Intel.
• The 14% drop in Eli Lilly presents a critical data point for the highly competitive weight-loss drug market, warranting a strategic review of positions in both LLY and its direct competitor Novo Nordisk.
• With a September rate cut almost fully priced in, investors should monitor for any shifts in Fed rhetoric or economic data that could challenge this consensus, as the market is now highly sensitive to surprises in monetary policy.
• The 8% decline in Airbnb on forward guidance suggests caution is warranted for growth-oriented stocks in the consumer discretionary space, as investors are heavily penalizing any signs of a slowdown.